Sun Pharmaceutical Industries Ltd share price logo

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA

BSE: 524715

Large Cap

Healthcare Sector

Pharma Sector

1794.20

+7.80

(+0.44%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Sun Pharmaceutical Industries Stock Performance

as on June 11, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,778.70
    ₹1,805.00
    downward going graph

    0.86%

    Downside

    0.60%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,548.00
    ₹1,916.60
    downward going graph

    13.72%

    Downside

    6.82%

    Upside

    downward going graph

Sun Pharmaceutical Industries share price movements today

Previous Close
₹1,786.40
Open
₹1,780.00
Volume
18.58L
Upper Circuit
₹1,965.00
Lower Circuit
₹1,607.80
Day's Low - High
₹1,778.70 - ₹1,805.00
52 Week Low - High
₹1,548.00 - ₹1,916.60

Sun Pharmaceutical Industries Historical Returns

1 Month Return
-2.79 %
3 Month Return
-1.7 %
1 Year Return
+ 6.33 %
3 Year Return
+ 82.07 %
5 Year Return
+ 164.98 %

Sun Pharmaceutical Industries Fundamentals

as on June 11, 2026 at 4:01 pm IST

Market Cap

₹4,30,488.68 Cr

Return on Equity (ROE)

17.83

PE Ratio (TTM)

37.54

Return on capital employed (ROCE)

16.29

Industry PE ratio

45.83

Beta (LTM)

0.54

P/B Ratio

17.11

Dividend Yield

0.92

PEG Ratio

17.06

Quarterly Earnings Growth YOY

26.06

EPS (TTM)

45.76

Book Value

301

Sun Pharmaceutical Industries Stock Valuation

as on June 11, 2026 at 4:01 pm IST

Sun Pharmaceutical Industries in the last 5 years

  • Overview

  • Trends

Lowest (19.47x)

March 23, 2020

Today (37.54x)

June 11, 2026

Industry (45.83x)

June 11, 2026

Highest (184.63x)

August 28, 2020

LowHigh

Today’s Price to Earnings Ratio: 37.54x

Sun Pharmaceutical Industries Technical Analysis

Track how Sun Pharmaceutical Industries technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish7
Bullish6
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.69
Bearish
CCI (20)
109.41
Bearish
RSI (14)
50.39
Neutral
Momentum (10)
-2.5
Bearish
ADI (14)
31.25
Bullish
Ultimate Oscillator (7,14,28)
33.88
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1796.7
Bearish
EMA (20)
1796.75
Bearish
VWMA (20)
1797.18
Bearish
SMA (50)
1794.35
Bullish
EMA (50)
1795.63
Bullish
SMA (200)
1798.01
Bearish
EMA (200)
1795.86
Bullish
KAMA (200)
1793.84
Bullish
DEMA (200)
1796.47
Bullish

Sun Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharmaceutical Industries with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY4,30,488.6833%0.5210,98052,578
HOLD1,76,682.6110.33%0.502,1919,360
BUY1,54,744.0241.38%0.872,13819,274
BUY67,421.660.19%0.781,42915,261
BUY38,047.95-5.4%0.536985,616

Market expectation of Sun Pharmaceutical Industries Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

87.50%

Buy

3.12%

Hold

9.38%

Sell

Sun Pharmaceutical Industries Stock’s Investor Sentiment and Interest

Investment in Sun Pharmaceutical Industries Ltd Shares on INDmoney has dropped by -49.63% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-49.63% versus previous 30 day period

Search interest for Sun Pharmaceutical Industries Ltd Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:40% versus previous 30 day period

Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
11,785.15
12,003.11
12,156.86
11,813.33
12,524.51
13,264.22
13,436.94
12,815.58
13,786.07
14,405.22
15,469.07
14,559.75
Other Income
204.44
293.61
250.2
605.94
532.55
354
465.62
612.87
464.46
469.92
578.84
458.5
Total Income
12,145.28
12,486.02
12,630.9
12,588.84
13,185.3
13,645.39
14,141.08
13,571.71
14,315.86
14,948.23
16,099.38
15,070.29
Expenses
8,931.94
9,013.03
8,973.68
9,049.39
9,045.13
9,352.43
9,982.61
9,604.43
10,367.74
9,951.26
11,061.53
10,657.59
Operating Profit
2,853.21
2,990.08
3,183.18
2,763.94
3,479.38
3,911.79
3,454.33
3,211.15
3,418.33
4,453.96
4,407.54
3,902.16
Operating Profit Margin %
24.21%
24.91%
26.18%
23.4%
27.78%
29.49%
25.71%
25.06%
24.8%
30.92%
28.49%
26.8%
Profit Before Interest, Tax and Depreciation
3,213.34
3,472.99
3,657.22
3,539.45
4,140.17
4,292.96
4,158.47
3,967.28
3,948.12
4,996.97
5,037.85
4,412.7
Interest
80.88
49.29
34.73
73.57
61.54
69.17
51.51
49.14
74.8
99.86
78.36
85.89
Depreciation
651.32
632.82
622.14
650.36
655.13
625.91
630.56
663.79
700.55
729.5
732.33
775.47
Profit Before Tax
2,481.14
2,790.88
3,000.35
2,815.52
3,423.5
3,597.88
3,476.4
3,254.35
3,172.77
4,167.61
4,227.16
3,551.34
Tax Paid
468.1
390.1
432.32
148.93
552.25
567.21
558.86
1,093.71
870.15
1,030.52
826.07
827.62
Profit After Tax
2,013.04
2,400.78
2,568.03
2,666.59
2,871.25
3,030.67
2,917.54
2,160.64
2,302.62
3,137.09
3,401.09
2,723.72
Total Net profit including share of profit / Loss from associate company
2,005.65
2,385.1
2,560.54
2,658.74
2,860.51
3,037.33
2,912.98
2,153.93
2,292.87
3,124.95
3,381.17
2,709.66
EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
Actual EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
Adjusted EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3
Diluted EPS
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
14
11.3

Sun Pharmaceutical Industries Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
26,065.94
28,686.28
32,325.17
33,233.08
38,426.42
43,278.87
47,758.45
52,041.25
58,220.11
Other Income
838.76
1,025.49
635.98
835.52
921.51
634.52
1,354.19
1,965.04
1,971.72
Total Income
27,328.22
30,091.4
33,473.48
34,333.66
39,576
44,520.2
49,851.04
54,543.48
60,433.76
Expenses
21,831.83
23,972.7
26,108.38
29,312.91
32,823.59
32,410.34
35,968.04
37,984.6
42,038.12
Operating Profit
4,234.11
4,713.58
6,216.79
3,920.17
5,602.83
10,868.53
11,790.41
14,056.65
16,181.99
Operating Profit Margin %
16.24%
16.43%
19.23%
11.8%
14.58%
25.11%
24.69%
27.01%
27.79%
Profit Before Interest, Tax and Depreciation
5,496.39
6,118.7
7,365.1
5,020.75
6,752.41
12,109.86
13,883
16,558.88
18,395.64
Interest
517.57
555.25
302.73
141.43
127.35
172
238.47
231.36
338.91
Depreciation
1,499.84
1,753.25
2,052.78
2,079.95
2,143.74
2,529.43
2,556.64
2,575.39
2,937.85
Profit Before Tax
3,478.98
3,810.2
5,009.59
2,799.37
4,481.32
9,408.43
11,087.89
13,752.13
15,118.88
Tax Paid
911.04
600.88
822.8
514.69
1,075.5
847.59
1,439.45
2,772.03
3,554.36
Profit After Tax
2,567.94
3,209.32
4,186.79
2,284.68
3,405.82
8,560.84
9,648.44
10,980.1
11,564.52
Total Net profit including share of profit / Loss from associate company
2,542.5
3,207.86
4,171.96
2,272.35
3,389.28
8,512.94
9,610.03
10,964.75
11,508.65
EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Actual EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Adjusted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8
Diluted EPS
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
47.8

Sun Pharmaceutical Industries Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
6,685.86
7,082.21
3,907.15
2,196.45
6,554.77
6,170.37
8,984.54
4,959.33
12,134.98
14,072.09
Cash Flow from Investing Activities
-3,949.13
-4,186.15
-3,103.8
-310.08
-2,225.32
406.53
-5,555.86
-7,219.92
-762.9
-5,183.15
Cash Flow from Financing Activities
-1,888.53
-2,285.39
-1,539.26
-2,730.52
-5,715.14
-5,980.48
-5,193.46
2,376.07
-6,710.16
-7,905.82
Net Cash Flow
848.2
610.67
-735.91
-844.15
-1,385.69
596.42
-1,764.78
115.48
4,661.92
983.12

Sun Pharmaceutical Industries Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
DII
19.67%
17.97%
18.83%
19.28%
18.61%
18.55%
18.7%
19.5%
20.23%
20.82%
21.11%
FII
16.79%
0%
17.72%
17.23%
18.02%
18.05%
17.96%
17.26%
16.55%
16.12%
15.93%
Public
9.06%
8.92%
8.97%
9.01%
8.89%
8.92%
8.87%
8.77%
8.73%
8.58%
8.48%
Total Outstanding Shares
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
Total Shareholders
6,16,588
6,12,626
6,31,392
6,73,217
6,57,317
6,89,623
7,04,983
7,23,770
7,43,877
7,10,900
6,90,957

Mutual Funds that own Sun Pharmaceutical Industries Stock

Check out the Mutual Funds with significant holdings in Sun Pharmaceutical Industries.

Sun Pharmaceutical Industries Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharmaceutical Industries.

  • Sun Pharmaceutical Industries Ltd Earnings Results

    Sun Pharmaceutical Industries Ltd’s net profit jumped 26.24% since last year same period to ₹2,714.03Cr in the Q4 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated -19.44% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Sun Pharmaceutical Industries Ltd Dividends January,2026

    In the quarter ending December 2025, Sun Pharmaceutical Industries Ltd has declared dividend of ₹11.00 per share on 31 Jan 2026 - translating a dividend yield of 1.51%.

    Read More about Dividends

Indices Featuring Sun Pharmaceutical Industries Stock

Check stock indices that include Sun Pharmaceutical Industries.

NIFTY PHARMA

₹24,306.95

0.61 (146.20%)

BSE 200

₹10,778.02

-0.51 (54.77%)

S&P BSE 250 LargeMidCap

₹10,252.63

-0.51 (52.93%)

SENSEX

₹73,832.55

-0.20 (150.63%)

Nifty 200

₹13,333.70

-0.48 (64.10%)

Nifty100 Eq Weig

₹32,965.95

-0.81 (268.70%)

S&P BSE 100 LargeCap TMC

₹8,699.30

-0.42 (36.61%)

Nifty 500

₹22,114.45

-0.54 (119.40%)

BSE Healthcare

₹47,100.72

0.25 (117.39%)

S&P BSE Low Volatility

₹1,714.69

-0.35 (6.07%)

Nifty Healthcare

₹15,500.50

0.33 (51.30%)

S&P BSE 100 ESG

₹391.44

-0.41 (1.60%)

BSE 100

₹24,571.58

-0.41 (102.07%)

S&P BSE SENSEX 50

₹24,234.72

-0.24 (58.14%)

BSE MFG

₹1,048.92

-0.38 (4.01%)

BSE 500

₹34,580.95

-0.53 (185.64%)

S&P BSE Dividend Stability

₹998.65

-1.06 (10.75%)

NIFTY 100

₹24,104.70

-0.40 (96.05%)

NIFTY 50

₹23,161.60

-0.23 (53.35%)

Nifty100 Low Volatility 30

₹19,198.25

-0.28 (53.30%)

Nifty LargeMidcap 250

₹15,829.65

-0.63 (100.80%)

Insights on Sun Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SUNPHARMA stock has moved up by 0.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.2% return, outperforming this stock by 33.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.48% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 147.1% return, outperforming this stock by 65.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 3.36K Cr → 2.71K Cr (in ₹), with an average decrease of 19.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 16.09K Cr → 15.07K Cr (in ₹), with an average decrease of 6.4% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.58% to 8.48% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 16.12% to 15.93% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 12.09% to 11.96% in Mar 2026 quarter

Sun Pharmaceutical Industries Stock Futures & Options Contracts

View the latest movement in Sun Pharmaceutical Industries Futures & Options, including strike prices, expiry dates, and percentage changes.

Sun Pharmaceutical Industries Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 30 Jun ₹1800 Call
June 30, 2026
₹1800
₹25.95
3.25
14.32%
SUNPHARMA 30 Jun ₹1820 Call
June 30, 2026
₹1820
₹16.55
2.4
16.96%
SUNPHARMA 30 Jun ₹1840 Call
June 30, 2026
₹1840
₹10.7
1.6
17.58%
SUNPHARMA 30 Jun ₹1860 Call
June 30, 2026
₹1860
₹7.05
0.7
11.02%

Sun Pharmaceutical Industries Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 30 Jun Fut
June 30, 2026
-
₹1805.5
7.91
0.44%
SUNPHARMA 28 Jul Fut
July 28, 2026
-
₹1811
6.5
0.36%
SUNPHARMA 25 Aug Fut
August 25, 2026
-
₹1806.9
13.09
0.73%

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd., incorporated in 1983, is a global specialty generic pharmaceuticals company with a presence in over 150 countries. The company is headquartered in Mumbai, India, and has operations in three primary lines of business: branded formulations, specialty generics, and active pharmaceutical ingredients (API).

Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.

Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.

Revenue: ₹14,559.75Cr as on March 2026 (Q4 FY26)
Net Profit: ₹2,723.72Cr as on March 2026 (Q4 FY26)
Listing date: 08 Feb, 1995
Revital Share Price
Volini Share Price
Abzorb Share Price
Pepfiz Share Price
OrganisationSun Pharmaceutical Industries Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Sun Pharmaceutical Industries share price today?

Sun Pharmaceutical Industries share price today stands at ₹1794.2 as on . Sun Pharmaceutical Industries share today touched a day high of ₹1805 and a low of ₹1778.7.

What is the 52 week high and 52 week low range for Sun Pharmaceutical Industries share?

Sun Pharmaceutical Industries touched a 52 week high of ₹1916.6 and a 52 week low of ₹1548. Sun Pharmaceutical Industries share price today i.e. is trending at ₹1794.2, which is -6.39% down from its 52 week high and 15.90% up from its 52 week low.

What is Sun Pharmaceutical Industries's market capitalisation today?

Sun Pharmaceutical Industries market capitalisation is ₹4,30,488.68 Cr as on .

How to buy Sun Pharmaceutical Industries shares?

To buy Sun Pharmaceutical Industries shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharmaceutical Industries shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharmaceutical Industries trading volume today?

Sun Pharmaceutical Industries trading volume is 18.58L as on . This means that 18.58L shares of Sun Pharmaceutical Industries were bought and sold on the stock market during today's trading session.